Recently, Descemet’s membrane endothelial keratoplasty has emerged as the preferred treatment for corneal endothelial dysfunction because it affords the best visual acuity with the lowest risk for various complications.
As the operation has grown more popular, various innovations to the technique have been introduced, including so-called “patient ready” DMEK, featuring “pre-stripped, stamped and stained” tissue. Despite the added convenience, “patient ready DMEK” necessitates the graft diameter to be specified in advance.
This obligation to specify in